At the start of every new year, experts prepare their economic forecasts. The year 2020 was tough. Therefore, experts struggled to make accurate predictions for 2021. The future situation in stock markets is a matter of concern to analysts. The fact is that the risks of unexpected losses and unsuccessful investments in these markets are extremely high. Recognized investment gurus have already made their choice for 2021. Read about their investment preferences for 2021 in our article
ফটোনিউজ: Top 5 pharm tycoons benefiting from COVID-19 pandemic
The coronavirus pandemic has played havoc with the global economy. The global community has to deal with the fallout from the crisis for long years ahead. Remarkably, this year has not been tough on everything. It goes without saying that stocks of pharmaceutical companies are extending a stellar rally. Though the pandemic is not the best time for new billionaires to emerge, pharmaceutical bosses have expanded their wealth on the back of soaring revenues of their businesses.